Physician profile
Niraja S Dalal
NPI 1386194132
$1,813.93
in general payments reported to CMS, 2019-2025
16 companies · $1,149 in 2025
The $1,149 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $488 · 2022: $91.93 · 2023: $46.81 · 2024: $37.96 · 2025: $1,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,234.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $895.05 | 2021-2025 | |
| Lilly USA, LLC | $217.72 | 2025 | Zepbound, Omvoh |
| Takeda Pharmaceuticals U.S.A., INC. | $170.39 | 2021-2025 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.53 | 2021-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $68.29 | 2021 | |
| Redhill Biopharma INC. | $63.73 | 2021 | |
| Genzyme Corporation | $49.89 | 2025 | |
| Novo Nordisk INC | $43.59 | 2025 | Wegovy |
| Ironwood Pharmaceuticals, INC | $37.53 | 2021 | |
| Ardelyx, INC. | $34.83 | 2025 | Ibsrela |
| Braintree Laboratories, INC. | $33.14 | 2021-2024 | Suflave |
| Qol Medical, LLC | $23.05 | 2025 | Sucraid |
| Nestle Healthcare Nutrition INC. | $21.49 | 2021 | |
| Celltrion USA INC. | $21.25 | 2025 | Vegzelma |
| Intercept Pharmaceuticals, INC. | $15.28 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $15.17 | 2025 | Iqirvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraja Dalal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.